BIOATLA, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation
BIOATLA, INC. (BCAB) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $0.00.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $556.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $746.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation $659.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-12-31 | $556.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $746.00K 10-K · filed 2025-03-28 |
| 2022-12-31 | $659.00K 10-K · filed 2024-03-26 |
| 2021-12-31 | $485.00K 10-K · filed 2023-03-23 |
| 2020-12-31 | $585.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |